- ABMD Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Abiomed (ABMD) 8-K29 Oct 20Abiomed Announces Q2 Fy 2021 Revenue of $210 Million, Up 27% Over Q1 Fy 2021 and Up 2% Over Q2 Fy 2020 with 29.2% Operating MarginFinancial data
Company Profile